QQ客服 官方微博 反馈留言

	Clinical pharmacokinetics, safety, and preliminary efficacy evaluation of icotinib in patients with advanced non-small cell lung cancer
	Liu, Dongyang; Zhang, Li; Wu, Yiwen; Jiang, Ji; Tan, Fenlai; Wang, Yingxiang; Liu, Yong; Hu, Pei
	2015
卷号	89期号:3页码:262-267
关键词	Clinical Pharmacokinetics Safety Activity Icotinib NSCLC Patients
ISSN号	0169-5002
DOI	10.1016/j.lungcan.2015.05.024
URL标识	查看原文
收录类别	SCIE ; PUBMED
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/6663063
专题	中国医学科学院 北京协和医学院
推荐引用方式 GB/T 7714	Liu, Dongyang,Zhang, Li,Wu, Yiwen,et al. Clinical pharmacokinetics, safety, and preliminary efficacy evaluation of icotinib in patients with advanced non-small cell lung cancer[J],2015,89(3):262-267.
APA	Liu, Dongyang.,Zhang, Li.,Wu, Yiwen.,Jiang, Ji.,Tan, Fenlai.,...&Hu, Pei.(2015).Clinical pharmacokinetics, safety, and preliminary efficacy evaluation of icotinib in patients with advanced non-small cell lung cancer.,89(3),262-267.
MLA	Liu, Dongyang,et al."Clinical pharmacokinetics, safety, and preliminary efficacy evaluation of icotinib in patients with advanced non-small cell lung cancer".89.3(2015):262-267.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。